[Addition of lithium to thymoleptic drugs in the treatment of therapy refractory depression].
The paper gives a short overview of the open and controlled investigations which have been published on the subject. The therapeutic efficacy of lithium addition is now quite well documented, and its use may be recommended in depressions refractory to conventional thymoleptic drug treatment. Preliminary conclusions with regard to the practical use of lithium addition are made.
Schöpf
J
J
Psychiatrische Universitätsklinik, Zürich.
D000928:Antidepressive Agents / Q000008:administration & dosage*; D002986:Clinical Trials as Topic; D003866:Depressive Disorder / Q000188:drug therapy* / Q000523:psychology; D004359:Drug Therapy, Combination; D006801:Humans; D008094:Lithium / Q000008:administration & dosage*; D016651:Lithium Carbonate
D000928:Antidepressive Agents; D016651:Lithium Carbonate; D008094:Lithium
Lithiumzugabe zu Thymoleptika als Behandlung therapieresistenter Depressionen.